US equities
|
MU
$935.80
▼-5.38%
META
$764.27
▲+2.87%
NVDA
$224.48
▼-0.81%
SNDK
$1,433.87
▼-3.59%
AAPL
$345.08
▲+1.21%
MSFT
$546.17
▲+0.93%
SPCX
$156.56
▼-4.20%
AMD
$585.51
▼-1.47%
MU
$935.80
▼-5.38%
META
$764.27
▲+2.87%
NVDA
$224.48
▼-0.81%
SNDK
$1,433.87
▼-3.59%
AAPL
$345.08
▲+1.21%
MSFT
$546.17
▲+0.93%
SPCX
$156.56
▼-4.20%
AMD
$585.51
▼-1.47%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about JP:4901
Recent news which mentions JP:4901
The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them
October 14, 2021
Tickers
APLIF
AVIR
MRK
PFE
Tags
RDY
MRK
PFE
From
MarketWatch